StreetInsider.com News Articles

FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Tue, 01 Sep 2026 07:30:00 -0400

Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026

FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026

AUSTIN, Texas, Sept. 01, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16,

FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Tue, 01 Sep 2026 07:30:00 -0400

Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026

FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026

H.C. Wainwright Reiterates Buy Rating on FocalTherics (FOCL)

Tue, 25 Aug 2026 07:00:37 -0400

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $10.00 price target on FocalTherics (NASDAQ: FOCL).

The analyst commented: "For 2Q26, FocalTherics reported 13 Focal One capital sales (8 US, 5 Int’l), up from 11 capital sales in 1Q26 (5 US, 6 Int’l), with 2Q26 representing the second-strongest quarter of capital sales to date (14 in 4Q25). Two of the US capital sales were operating lease conversions (from the University of Michigan and Vanderbilt University Medical Center), consistent with management's stated shift toward leading with cash sales rather than lease agreements. The installed base reached 184 systems (96 US, 88

Form 8-K EDAP TMS SA For: Aug 14

Wed, 19 Aug 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260819/26946786.html

Form 8-K EDAP TMS SA For: Aug 14

Wed, 19 Aug 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260819/26946786.html

Form 8-K EDAP TMS SA For: Aug 14

Wed, 19 Aug 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260819/26946786.html

Form 10-Q EDAP TMS SA For: Jun 30

Fri, 14 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260814/26930087.html

Form 10-Q EDAP TMS SA For: Jun 30

Fri, 14 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260814/26930087.html

Form 10-Q EDAP TMS SA For: Jun 30

Fri, 14 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260814/26930087.html

Edap TMS SA (FOCL) PT Raised to $4 at Piper Sandler

Fri, 14 Aug 2026 08:26:28 -0400

Piper Sandler analyst Jason Bednar raised the price target on Edap TMS SA (NASDAQ: FOCL) to $4.00 (from $3.00) while maintaining a Neutral rating.

Form 8-K EDAP TMS SA For: Aug 11

Fri, 14 Aug 2026 06:08:00 -0400

si-local-file:///var/storage/secattach/20260814/26924056.html

Form 8-K EDAP TMS SA For: Aug 11

Fri, 14 Aug 2026 06:08:00 -0400

si-local-file:///var/storage/secattach/20260814/26924056.html

Form 8-K EDAP TMS SA For: Aug 11

Fri, 14 Aug 2026 06:08:00 -0400

si-local-file:///var/storage/secattach/20260814/26924056.html

FocalTherics™ Reports Second Quarter 2026 Financial Results

Thu, 13 Aug 2026 16:02:00 -0400

39% Revenue Increase and 47% Growth in U.S. Procedures

FocalTherics™ Reports Second Quarter 2026 Financial Results

39% Revenue Increase and 47% Growth in U.S. Procedures

AUSTIN, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced financial results for the second quarter of 2026. This marks the Company's first reporting period presenting its HIFU business as continuing operations and its ESWL and Distribution businesses as discontinued operations.

Second Quarter 2026 Results and Recent Highlights of Continuing Operations (HIFU Segment)

Increased

FocalTherics™ Reports Second Quarter 2026 Financial Results

Thu, 13 Aug 2026 16:02:00 -0400

39% Revenue Increase and 47% Growth in U.S. Procedures

FocalTherics™ Reports Second Quarter 2026 Financial Results

39% Revenue Increase and 47% Growth in U.S. Procedures

Second Quarter 2026 Results and Recent Highlights of Continuing Operations (HIFU Segment)

Increased

Form 8-K EDAP TMS SA For: Aug 13

Thu, 13 Aug 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260813/26920604.html

Form 8-K EDAP TMS SA For: Aug 13

Thu, 13 Aug 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260813/26920604.html

Form 8-K EDAP TMS SA For: Aug 13

Thu, 13 Aug 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260813/26920604.html

Form 424B5 EDAP TMS SA

Wed, 12 Aug 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260812/26914378.html

Form 424B5 EDAP TMS SA

Wed, 12 Aug 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260812/26914378.html

Form 424B5 EDAP TMS SA

Wed, 12 Aug 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260812/26914378.html

Form 424B5 EDAP TMS SA

Wed, 12 Aug 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260812/26908269.html

Form 424B5 EDAP TMS SA

Wed, 12 Aug 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260812/26908269.html

Form 424B5 EDAP TMS SA

Wed, 12 Aug 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260812/26908269.html

FocalTherics prices public offering of 8.4 million ADS at $4.75 each

Tue, 11 Aug 2026 21:10:17 -0400

FocalTherics (NASDAQ: FOCL) has priced an underwritten public offering of 8,425,000 American Depositary Shares (ADSs) at $4.75 per ADS, according to a press release from the company.

Each ADS represents one ordinary share of the company, with a nominal value of €0.13 per share. All ADSs are being sold by the company. The gross proceeds from the offering are expected to be approximately $40.0 million before underwriting discounts, commissions, and other expenses.

The underwriters have been granted a 30-day option to purchase up to an additional 1,263,750 ADSs at the public offering price, less underwriting discounts and commissions. The offering is expected